Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific : a subanalysis of the EPIC study of deferasirox
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-03-01
著者
-
Li Chi-kong
Prince Of Wales Hospital Chinese University Of Hong Kong
-
VIPRAKASIT Vip
Haematology-Oncology Division, Department of Paediatrics and Thalassaemia Center, Faculty of Medicin
-
IBRAHIM Hishamshah
Hospital Kuala Lumpur
-
HA Shau-Yin
Queen Mary Hospital, The University of Hong Kong
-
HO Phoebe
Royal Prince Alfred Hospital
-
CHAN Lee-Lee
University Malaya Medical Centre
-
CHIU Chang-Fang
China Medical University Hospital
-
SUTCHARITCHAN Pranee
Chulalongkorn University and King Chulalongkorn Memorial Hospital
-
HABR Dany
Novartis Pharmaceuticals Corp
-
DOMOKOS Gabor
Novartis Pharma AG
-
ROUBERT Bernard
Novartis Pharma AG
-
XUE Hong-Ling
Novartis Asia Pacific Pharmaceuticals
-
BOWDEN Donald
Monash Medical Centre
-
LIN Kai-Hsin
National Taiwan University Hospital
-
Ha Shau-yin
Queen Mary Hospital The University Of Hong Kong
-
Viprakasit Vip
Haematology-oncology Division Department Of Paediatrics And Thalassaemia Center Faculty Of Medicine